Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_01086 |
| Species: | Homo sapiens |
| Position : | chr2:16370000-16380000 |
| Year: | 2020 |
| Title: | Enhancer hijacking determines extrachromosomal circular MYCN amplicon architecture in neuroblastoma |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | neuroblastoma |
| PMID: | 33199677 |
| MONDO: | MONDO:0005070 |
| Tissue: | Adrenal gland |
| Tissue Ontology ID: | UBERON:0002369 |
| Cell Source: | Kelly |
| CVCL ID: | CVCL_1375 |
| Cell Type: | neuroblastoma cell |
| Cell Ontology ID: | CL:0000031 |
| Experiment Type: | Enhancer activity assay, TF binding assay, Chromatin interaction assay |
| High Throughput Method: | ChIP-seq, RNA-seq, ATAC-seq, 3C-seq |
| Low Throughput Method: | qRT-PCR, and ChIP-qPCR |
| Target gene : | MYCN |
| TF name : | PHOX2B; HAND2; GATA3 |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_01085 | chr2:16370000-16380000 | Bone Marrow | B lymphoblast | B-cell acute lymphoblastic leukemia |